nickel has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, CJ; Sun, X | 1 |
| Roesch, F | 1 |
2 other study(ies) available for nickel and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
| Article | Year |
|---|---|
Production and applications of copper-64 radiopharmaceuticals.
Topics: Animals; Antibodies; Antigen-Antibody Reactions; Chelating Agents; Copper Radioisotopes; Cyclotrons; Half-Life; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Nickel; Nuclear Medicine; Organometallic Compounds; Peptides; Radioligand Assay; Radiopharmaceuticals; Somatostatin; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Scandium-44: benefits of a long-lived PET radionuclide available from the (44)Ti/(44)Sc generator system.
Topics: Adsorption; Animals; Cation Exchange Resins; Chelating Agents; Drug Stability; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplasms, Experimental; Nickel; Nuclear Reactors; Positron-Emission Tomography; Puromycin; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals; Scandium; Titanium; Transplantation, Heterologous | 2012 |